SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-208186
Filing Date
2020-08-03
Accepted
2020-08-03 17:05:56
Documents
5
Period of Report
2020-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d68777d8k.htm 8-K 27796
2 EX-99.1 d68777dex991.htm EX-99.1 14729
3 EX-99.2 d68777dex992.htm EX-99.2 8436
4 GRAPHIC g68777g0803011341579.jpg GRAPHIC 4937
5 GRAPHIC g68777g94y02.jpg GRAPHIC 14249
  Complete submission text file 0001193125-20-208186.txt   73645
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 201069939
SIC: 2834 Pharmaceutical Preparations